The HEALEY ALS platform trial, the first study to test several therapy candidates for amyotrophic lateral sclerosis (ALS) simultaneously, has completed enrollment for at least two of its first three regimens. These include Clene Nanomedicine’s CNM-Au8 (NCT04414345) and Biohaven Pharmaceuticals’ verdiperstat (NCT04436510). The recruitment status for the other initial arm of the trial, UCB’s zilucoplan (NCT04436497), remains unclear, but all three regimens […]

OpRegen (Lineage Cell Therapeutics) has continued to show safety and efficacy in patients with dry age-related macular degeneration (AMD) with geographic atrophy (GA), according to recent data from a phase 1/2a clinical trial (NCT02286089).1,2 The data were presented at the American Academy of Ophthalmology (AAO) 2021 Meeting, November 12-15, by Michael S. Ip, MD, University of California Los Angeles, Doheny Eye […]

Advanced Human Imaging (AHI) is a company like no other in the Digital Health space. The Australian company aims to put your smartphone at the center of the healthcare journey by combining the best portable technologies and leveraging machine learning algorithms. The famous photographer Chase Jarvis once said, “the best camera is the one you have with […]